BTK blockers make headway in multiple sclerosis
Elie Dolgin • January 11, 2021
By targeting both arms of the immune system, not just B cells, brain-penetrant inhibitors of Bruton’s tyrosine kinase could improve on anti-CD20 therapy for patients with multiple sclerosis.
Continue reading at Nature Biotechnology.
A shadow-sensing skill known as skototaxis helps cicadas find trees to molt on.
In a small trial, the simulation pinpoints the source of faulty beats and speeds procedure time.